At what age can women discontinue Pap (Papanicolau) smear screening?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Age for Discontinuing Pap Smear Screening

Women should discontinue cervical cancer screening after age 65 years if they have had 3 consecutive negative cytology tests or 2 consecutive negative cotest results within the 10-year period before ceasing screening, with the most recent test occurring within the last 5 years. 1

Criteria for Discontinuing Screening

The decision to stop screening at age 65 is based on several key factors:

  • Adequate prior screening history is defined as:

    • 3 consecutive negative cytology (Pap) tests OR
    • 2 consecutive negative HPV-cytology cotests within the past 10 years
    • Most recent test must have occurred within the last 5 years 1
  • Once screening is discontinued, it should not resume for any reason, including if a woman has a new sexual partner 1

Special Considerations and Exceptions

Certain women should continue screening beyond age 65:

  • Women with a history of CIN2, CIN3, or adenocarcinoma in situ should continue routine screening for at least 20 years after treatment, even if this extends screening past age 65 1

  • Women who have not been adequately screened previously should continue screening until they meet the criteria for discontinuation 1

  • Women at higher risk should continue screening beyond age 65, including those who:

    • Have a history of cervical cancer
    • Were exposed to diethylstilbestrol (DES) in utero
    • Are immunocompromised (organ transplantation, chemotherapy, chronic corticosteroid treatment)
    • Are HIV-positive 1

Women with Hysterectomy

  • Women who have had a total hysterectomy with removal of the cervix and have no history of high-grade precancerous lesions or cervical cancer should discontinue screening 1

  • Women who have had a hysterectomy but still have their cervix should continue screening according to age-appropriate guidelines 1

  • Women who have had a hysterectomy with removal of the cervix but have a history of CIN2 or more severe diagnosis should continue screening 1

Evidence and Rationale

The recommendation to discontinue screening at age 65 is based on evidence that:

  • The risk of developing cervical cancer after age 65 is very low in adequately screened women

  • Modeling data suggest that continued testing of previously screened women reduces the risk of cervical cancer mortality by only 0.18% at age 65 and 0.06% at age 74 1

  • However, some research suggests higher rates of abnormal Pap smears in certain elderly populations, particularly among Black women and other minority groups 2

Common Pitfalls to Avoid

  1. Continuing unnecessary screening: Approximately 40.8% of women over 70 years still receive Pap smears despite guidelines recommending discontinuation 3

  2. Provider-driven overscreening: Nearly 40% of women ≥70 years report receiving a recommendation for Pap testing from their provider in the past year 3

  3. Stopping screening too early: Women without adequate prior screening history should not discontinue at age 65 1

  4. Failing to recognize high-risk groups: Women with history of high-grade lesions or other risk factors need continued screening 1

Following these evidence-based guidelines will help optimize cervical cancer screening by balancing the benefits of early detection against the potential harms of unnecessary procedures in older women.

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.